Immunology. TriKes. CAR-T cells. Tune in on Thursday, August 20 for a discussion that decodes medical buzzwords and highlights the latest breakthroughs in cancer research. Funds raised by the Killebrew-Thompson Memorial support St. Luke's Cancer Institute and the Masonic Cancer Center, University of Minnesota. Leading doctors from these institutions will present clinical studies and recent advancements in cancer treatment and care and how they offer hope for finding a cure.
Moderated by Dr. Tucker LeBien, Director, Office of Discovery and Translation, Clinical and Translational Science Institute (CTSI), the forum features Dr. Brenda Weigel, Director of Pediatric Hematology and Oncology, Masonic Cancer Center, University of Minnesota and Dr. Dan Zuckerman, Medical Director, St. Luke's Cancer Institute.
Dr. Dan Zuckerman Medical Director St. Luke's Cancer Institute | Dr. Brenda Weigel Director of Pediatric Hematology and Oncology Masonic Cancer Center, University of Minnesota | Dr. Tucker LeBien Director, Office of Discovery and Translation University of Minnesota Medical School |
Webcast Hosted by KTM Beneficiaries